There is a potential breakthrough for patients who could be in danger of losing their vision. A first-of-its-kind treatment is now being used in Massachusetts. Kevin Ratcliffe is a glaucoma patient at ...
Lexeo Therapeutics said Wednesday that it received positive data for its Alzheimer's disease treatment, which suggests that higher doses improved results. The clinical-stage genetic medicine company ...